| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |